ArticlePloS one2025
German validation of three ethics questionnaires: Consequentialist scale, ethical standards of judgment questionnaire, and revised ethics position questionnaire.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Consequentialist Scale (CS) and the Ethical Standards of Judgment Questionnaire (ESJQ) are instruments developed to evaluate the extent of moral reasoning in relation to the two pivotal factors that appear to influence moral decision-making: the degree of harm or benefit produced by the action in question and the consistency of the action with moral norms. In other words, they assess the propensity to utilitarian versus deontological moral reasoning. In contrast, the Ethical Position Questionnaire (EPQ-5) conceptualizes ethical idealism and ethical relativism as meaning-independent, orthogonal dimensions. This study aimed to assess the psychometric properties of German versions of the three mentioned scales in a sample of native German speakers.
methodsA convenience sample of 263 participants completed the online survey. Analyses included internal consistency, structural validity, construct validity through the known-groups method, retest-reliability with a subgroup of n = 102, and floor and ceiling effects. This study used the STROBE checklist.
resultsThe CS and EPQ-5 showed strong psychometric properties without any noticeable weaknesses. In contrast, the ESJQ displayed significant shortcomings across all analyses, with low internal consistency and poor results in both item analysis and confirmatory factor analysis. The results indicated that deontology, formalism, and idealism were positively correlated with age, while only idealism correlated significantly with gender, with females scoring higher on the idealism scale. A positive correlation was observed between deontology and formalism with religiosity. With regard to personality, deontology and idealism demonstrated a positive correlation with conscientiousness, whereas utilitarianism exhibited a negative correlation with conscientiousness. A positive correlation between consequentialism and openness was also identified, while a negative correlation between formalism and agreeableness was evident.
conclusionThe German versions of the CS and EPQ-5 are reliable and valid instruments for measuring the propensity toward utilitarian and deontological approaches, as well as ethical idealism and relativism. The scales, therefore, serve as invaluable tools for research, training, and professional practice, facilitating comprehension of the aspects of conscious reflection on ethical dilemmas in practice and of responsible action. The ESJQ, however, did not perform well psychometrically in the German translation, as its internal consistency is questionable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.